Study results for glioblastoma drug
Summer 2013 : Drug study shows no benefit for newly diagnosed glioblastoma
Drug study shows no benefit for newly diagnosed glioblastoma
Bevacizumab offers no benefit for newly diagnosed glioblastoma (brain) cancer patients, an MD Anderson-led study finds. Investigators discuss their study in the frontline setting for the treatment of glioblastoma.
Guests: Mark Gilbert, M.D. and Minesh Mehta, M.D., Ph.D.
More Episodes From Cancer Newsline
